Keywords: ATRA; CSC; cancer stem cells; EMT; epithelial to mesenchymal transition; MET; mesenchymal to epithelial transition; AML; acute myeloid leukemia; ALDH1; aldehyde dehydrogenase 1; BCSC; breast cancer stem cell; Lgr5; G-protein-coupled receptor 5; GSC; glioblastom
مقالات ISI ATRA (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ATRA; ATRA; ATO; CML; Promyelocytic; Blast crisis;
Keywords: ATRA; Cyanobacteria; Retinoids; Retinoid-like activity; Extract; Exudates; ATRA;
Keywords: ATRA; AGE; advanced glycation end products; AICAR; 5-Aminoimidazole-4-carboxamide ribonucleotide; AMPK; 5â² adenosine monophosphate-activated protein kinase; APC; antigen-presenting cell; Atg7; autophagy-related gene 7; ATP; adenosine triphosphate; ATRA; all-t
Keywords: ATRA; ATRA; all-trans retinoic acid; AF; activation function; ESI; electronic supplementary information; GZ; compound series code; H12; helix 12; LBD; ligand binding domain; RAR; retinoic acid receptor; RARE; retinoic acid response element; RXR; retinoid X rece
Keywords: ATRA; Photochemisrty; Halogen-bond; ATRA; Alkynes; Perfluoroalkyl iodides;
Keywords: ATRA; GBM; Glioblastoma multiforme; CARs; chimeric antigen receptors; PDL1; programmed death ligand 1; IDH1; isocitrate dehydrogenase 1; PMN; polymorphonuclear; TAMs; tumor associated macrophages; HLA; human leucocyte antigen; FLT3L; Fms-like tyrosine kinase 3
Keywords: ATRA; [AMIM]Cl; 1-allyl-3-methylimidazolium chloride; AGET; activator generated by electron transfer; AIBN; azobisisobutyronitrile; AMIMBr; 1-allyl-3-methylimidazolium bromide; ATRA; atom transfer radical additions; ATRP; atom transfer radical polymerization; A
Keywords: ATRA; AFM; atomic force microscopy; AIBN; azobisisobutyronitrile; AN; acrylonitrile; ARGET; activators regenerated by electron transfer; ATRP; atom transfer radical polymerization; ATRA; atom transfer radical addition; BA; n-butyl acrylate; BIPE; bis(2-iodoprop
Keywords: ATRA; TANs; tumor associated neutrophils; TENs; tumor entrained neutrophils; ROS; reactive oxygen species; NETs; neutrophils extracellular traps; ACEi; angiotensin-converting enzyme inhibitors; ATRA; all-trans-retinoic acid; APL; acute promyelocytic leukemia; D
Keywords: ATRA; ATR; Achilles tendon rupture; AT; Achilles tendon; ATRA; Achilles Tendon Resting Angle; ATLM; Achilles Tendon Length Measure; Achilles Tendon Length Measure; Achilles Tendon Resting Angle; Reliability; Achilles tendon rupture; Elongation;
Keywords: ATRA; Microenvironment; Resistance; Target therapy; AML; acute myeloid leukemia; ATRA; all-trans retinoic acid; bFGF; basic fibroblast growth factor; CAFs; cancer-associated fibroblasts; CAM-DR; cell adhesion-mediated drug resistance; CCL2; chemokine (C-C motif
Keywords: ATRA; ATRA; all-trans retinoic acid; BMP4; bone morphogenetic protein 4; ES; embryonic stem; IPS; induced pluripotent stem; K14; keratin 14; MSCs; mesenchymal stem cells; Muse; multilineage-differentiating stress enduring; Muse-Fb; Muse cell-derived fibroblasts
Keywords: ATRA; ABC transporters; ATP binding cassette transporters; ALD; adrenoleukodystrophy; APL; acute promyelocytic leukemia; APTEDB; extra-domain B-specific aptide; ATP; adenosine triphosphate; ATRA; all-trans retinoic acid; BBB; blood-brain-barrier; BCRP; breast c
Keywords: ATRA; atRA; all-trans retinoic acid; CRBP; cellular retinol binding protein; CYP26; cytochrome P450; DEAB; 4-diethylaminobenzaldehyde; DMSO; dimethylsulfoxide; RA; retinoic acid; RAR; retinoic acid receptor; RBP; retinol binding protein; RDH; retinol deshydroge
Keywords: ATRA; Liposomes; ATRA; DOTAP; Cholesterol; Nano-scale; Dialysis membrane;
Keywords: ATRA; ALDH; aldehyde dehydrogenase; APL; acute promyelocytic leukemia; ATRA; all trans retinoic acid; BBB; blood-brain-barrier; b-FGF; basic fibroblast growth factor; BMP; bone morphogenetic protein; CSC; cancer stem cells; ECM; extracellular matrix; EGFR; epid
Keywords: ATRA; Guar gum; Styrene; ATRA;
Keywords: ATRA; 13-cis-RA; 13-cis-retinoic acid; 9-cis-RA; 9-cis-retinoic acid; ATRA; all-trans-retinoic acid; dTP; developmental toxicity potential concentration; dTT; developmental toxicity threshold; HRMS; high resolution mass spectrometry; ISTD; internal standard; o/
Keywords: ATRA; AD; Alzheimer's disease; ANEP; anti-neuroexcitation peptide; APTS; aminopropyltriethoxysilane; atRA; All-trans-retinoic acid; BBB; blood-brain barrier; BMP; bone morphogenetic protein; BSA; bovine serum albumin; CA; cyanoacetate; CCM; Czech Collection o
Keywords: ATRA; AP-1; activator protein 1; APEX1; , DNA-(apurinic or apyrimidinic site) lyase; AP-MS; , affinity purification followed by mass spectrometry; ARID3A; , AT-rich interactive domain-containing protein 3A; Asc/Men; , ascorbate/menadione; ATRA; , all-trans-Reti
Keywords: ATRA; 2,4-D; 2,4-dichlorophenoxyacetic acid; 4-VP; 4-vinylpyridine; AAm; acrylamide; AIBN; azobisisobutyronitrile; ATRA; atom transfer radical addition; ATRP; atom transfer radical polymerization; BDC; benzyl diethyldithiocarbamate; BET; Brunauer-Emmett-Tel
Keywords: ATRA; ATRA; Peripheral nerve fibroblasts; Viability; Apoptosis
Keywords: ATRA; Pin1; the peptidyl-prolyl cis-trans isomerase; SRC-3/AIB1; steroid receptor coactivator 3; FAK; focal adhesion kinase; Mcl-1; myeloid cell leukemia-1; p70S6K; ribosomal S6 kinase; Stat3; signal transducers and activators of transcription 3; PKB/Akt; serin
Keywords: ATRA; Ethanol; CYP2E1; Reactive oxygen species; Mitochondrial membrane potential; Energy metabolism; ATRA
Keywords: ATRA; RA; retinoic acid; Retinoids; RA and its derivatives; atRA; all-trans RA; RAR; retinoic acid receptor; RXR; retinoid X receptor; LXR; liver X receptor; PKA; protein kinase A; (Bu)2cAMP; dibutyryl adenosine 3â²,5â² cyclic monophosphate; StAR; steroidogen
Keywords: ATRA; SHetA2; N-(2,3-dihydro-2,2,4,4-tetramethyl-6-benzothiopyranyl), Nâ²-(4-nitrophenyl)thiourea; ATRA; all trans retinoic acid; NOAEL; no observed adverse effect level; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTS; MTT coupled with
Keywords: ATRA; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ATRA; all-trans retinoic acid; BHA; butylated hydroxyanisole; C/EBP; CCAAT/enhancer binding proteins; CREB; cyclic AMP response element-binding proteins; CSF; cerebrospinal fluid; DUOX; dual
Keywords: ATRA; Epigenetic modifiers; Chromatin; Therapy; Cancer; Histone profiles; ac; acetyl; ATRA; all-trans retinoic acid; BrD; bromodomain; FL; follicular lymphoma; H; histone; HAT; histone acetyltransferase; HDAC; histone deacetylase; HMT; histone methyltransferase
Keywords: ATRA; 4-AP; 4-aminopyridine; APC; antigen presenting cell; ApoE; apolipoprotein E; ATRA; all-trans-retinoic acid; BBB; blood brain barrier; BBI; Bowman-Birk inhibitor; CB1/2; cannabinoid receptor; CBD; cannabidiol; CNS; central nervous system; DC; dendritic c
Keywords: ATRA; ATRA; Death; Leukemia; Promyelocytic;
Keywords: ATRA; CoCl2; cobalt chloride; AML; acute myeloid leukemia; HIF-1 α; hypoxia-inducible factor-1 α; CQ; chloroquine; LAMP1 and 2; lysosome-associated membrane proteins 1 and 2; APL; acute promyelocytic leukemia; ATRA; all-trans retinoic acid; ATO; arsenic triox
Keywords: ATRA; HCC; hepatocellular carcinoma; RA; retinoic acid; RAR; retinoic acid receptor; RARE; retinoic acid response element; ChIP; chromatin immunoprecipitation; EST; expression sequence tag; ATRA; all-trans retinoic acid; RT-PCR; reverse transcription-polymerase
Keywords: ATRA; NIHL; noise-induced hearing loss; ATRA; all trans retinoic acid; Prdx 6; peroxiredoxin 6; RARE; retinoic acid-response element; RAR; retinoic acid receptors; All-trans retinoic acid; Noise-induced temporary threshold shift; Cochlea; Peroxiredoxin 6; Retin
Keywords: ATRA; MN; microneedle; ATRA; all-trans retinoic acid; TT; tetanus toxoid; DT; diphtheria toxoid; OV; ovalbumin; FITC-OVA; fluorescein isothiocyanate-labeled ovalbumin; HPLC; high-performance liquid chromatography; ERH; equilibrium relative humidity; ID; intra
Keywords: ATRA; 4-HNE; 4-hydroxynonenal; 15d-PGJ2; 15-deoxy-â12,14-prostaglandin J2; AP-1; activator protein-1; As3 +; trivalent arsenite; α-SMA; a-smooth muscle actin; ARE; antioxidant response element; ATRA; all-trans retinoic acid; BDL; bile duct ligation; BHMT; b
Keywords: ATRA; SK; seborrheic keratosis; FGFR3; somatic fibroblast growth factor receptor 3; ATRA; all-trans retinoic acid; HB-EGF; heparin-binding epidermal growth factor-like growth factor; EGFR; epidermal growth factor receptor; MN; microneedle; HE; hematoxylin and e
Keywords: ATRA; GRIP1; glucocorticoid receptor-interacting protein 1; TIF2; translation initiation factor 2; SRC; steroid receptor coactivator; NR; nuclear receptor; AD; activation domain; CBP; CREB binding protein; APL; acute promyelocytic leukemia; RAR; retinoic acid r
Keywords: ATRA; Macrophage; dendritic cell; lipid; nuclear receptor; retinoid X receptor; retinoic acid receptor; peroxisome proliferator-associated receptor; liver X receptor; vitamin D receptor; rheumatoid arthritis; inflammatory bowel disease; systemic lupus erythemat
Keywords: ATRA; acute promyelocytic leukemia; all-trans retinoic acid; APL; ATRA; hemorrhage; intracranial hemorrhage; leukemia;
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA
Keywords: ATRA; Acute promyelocytic leukemia; Arsenic trioxide; ATRA; Combination therapy;
LncRNA HOXA-AS2 and its molecular mechanisms in human cancer
Keywords: ATRA; lncRNA; HOXA-AS2; Diagnosis; Therapeutic target; Prognosis; APL; Acute promyelocytic leukemia; ATRA; All trans retinoic acid; Bax; BCL2-Associated X; BC; Breast cancer; Bcl-2; B-cell lymphoma-2; c-Myc; MYC proto-oncogene; CRC; Colorectal cancer; DDIT3; DN
Dihydromyricetin sensitizes human acute myeloid leukemia cells to retinoic acid-induced myeloid differentiation by activating STAT1
Keywords: ATRA; Myeloid differentiation; Acute myeloid leukemia; Dihydromyricetin; ATRA; STAT1;
Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature
Keywords: ATRA; Acute myelocytic leukemia (AML); Secondary clone; Myelodysplastic syndrome (MDS); Therapy-related acute myelocytic leukemia (t-AML); Therapy-related myelodysplastic syndrome (t-MDS); AML; acute myelocytic leukemia; APL; acute promyelocytic leukemia; ATO;
Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines
Keywords: ATRA; ATRA; all-trans retinoic acid; RA; retinoic acid; CCR9; chemokine receptor 9; WGLF; whole gut lavage fluid; Retinoic acid; α4β7; CCR9; Gut mucosa; Vaccines;
Reduced RAR-β gene expression in Benzo(a)Pyrene induced lung cancer mice is upregulated by DOTAP lipo-ATRA treatment
Keywords: ATRA; RAR; retinoic acid receptor; RXR; retinoid X receptor; ATRA; of all Trans retinoic acid; APL; acute promyelocytic leukaemia; RARE; retinoic acid responsive elements; NSCLC; non-small cell lung cancer; B(a)P; benzo (a) pyrene; DOTAP; 1,2-Dioleoyl-3-trimeth
Edaravone, a cytoprotective drug, enhances transgene expression mediated by lipoplexes in HepG2 cells and mice
Keywords: ATRA; ALT; alanine transaminase; AST; aspartate transaminase; ATRA; all-trans retinoic acid; DMEM; Dulbecco's modified Eagle's medium; DOTAP; 1,2-dioleoyl-3-trimethylammonium-propane; EDLP; edaravone-loaded liposome; EE; encapsulation efficiency; FBS; fetal
γ-Mangostin, a xanthone from mangosteen, attenuates oxidative injury in liver via NRF2 and SIRT1 induction
Keywords: ATRA; ALT; alanine aminotransferase; ARE; antioxidant responsive element; AST; aspartate transaminase; ATRA; all--retinoid acid; CCl4; carbon tetrachloride; DCFH-DA; 2â²,7â²-dichlorofluorescin diacetate; γ-man; γ-mangostin; GSH; glutathione; HO-1; heme oxyg
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Keywords: ATRA; MDSC; Melanoma; ATRA; Ipilimumab; Randomized Clinical Trial; Immunotherapy;
NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells
Keywords: ATRA; NDPK; nucleoside diphosphate kinase; ATRA; all-trans retinoic acid; EA; ellagic acid; AML; acute myelogenous leukemia; LPA; lysophosphatidic acid; EDG2/lpal; endothelial differentiation gene 2/LPA receptor 1; BC; breast cancer; NM23; EDG2/lpa1; ATRA; Myel